News | June 29, 2011

Study Demonstrates Discrepancies in Nuclear Cardiology Reporting, Yet Improvement with ICANL Accreditation


June 29, 2011 — A new study from the Intersocietal Commission for the Accreditation of Nuclear Medicine Laboratories (ICANL) suggests that while noncompliance with reporting standards is found in the majority of nuclear cardiology laboratories throughout the U.S., facilities participating in the ICANL accreditation process demonstrate an increase in compliance over time.

According to the study, published June 19 in the <i>Journal of Nuclear Cardiology,</i> a majority of facilities (57.2 percent) were noncompliant with more than one of the required reporting elements. The data also demonstrated that there were identifiable site characteristics that define which laboratories are more likely to be noncompliant. For instance, certain regions of the United States and facility settings were associated with greater noncompliance.

Most significantly, the study demonstrates that the ICANL accreditation process has a significant impact on quality. Researchers found that as laboratories apply in subsequent three-year cycles, there is an increase in the compliance of the generated report with the national standards. This continuous improvement illustrates that feedback from the accreditation review is integrated by the laboratories into their daily process, thus completing the quality cycle.

Lead author Peter L. Tilkemeier, M.D., notes that while the ICANL accreditation process has been in existence since 1997, this is the first time that the quality of nuclear cardiology reports has been evaluated for compliance with the <i>ICANL Standards.</i>

“As the final report is the single most important part of a nuclear cardiology study, it is very powerful to learn through this study that accreditation is contributing greatly to nuclear cardiology facilities’ ability to improve their reports,” Tilkemeier said.

In the recent study, site characteristics and the 18 elements of the ICANL nuclear reporting standards were evaluated in 1,301 laboratories applying for accreditation during a one-year period, beginning Jan. 1, 2008. Of the 18 report elements, the most frequent noncompliant items were: missing date of report (26.4 percent), separate stress and imaging reports (23.6 percent), missing the route of administration of radiopharmaceutical (22.8 percent) and no mention of the defect size, severity, type and location using standardized terminology (19.8 percent).

The ICANL is an instrument driving the improvement process by promoting uniform performance among laboratories with different characteristics such as study volume, laboratory type and geographic location notes Mary Beth Farrell, MS, CNMT, director of nuclear and PET accreditation for the Intersocietal Accreditation Commission (IAC).

“By identifying specific noncompliant reporting elements and site characteristics associated with noncompliance, we can now target educational activities to help laboratories improve the quality of reporting and facilitate successful accreditation,” Farrell said.

A follow-up editorial written by Frans J. Th. Wackers, M.D., Ph.D., FASNC, entitled “The Art of Communicating: The Nuclear Cardiology Report” was published June 25 in the ;Journal of Nuclear Cardiology. The editorial confirms the analysis revealing that the majority of laboratories applying for ICANL accreditation demonstrate noncompliance with reporting standards. In addition, the editorial emphasizes the significance of the nuclear cardiologist’s responsibility to provide comprehensive and clinically useful reports.

A nonprofit organization established in 1997, the ICANL is dedicated to promoting quality nuclear cardiology, nuclear medicine and PET imaging in the delivery of health care by providing a peer review process of laboratory accreditation. The ICANL is a member of the IAC, a nonprofit organization that provides facility accreditation programs for vascular, echocardiography, nuclear cardiology/nuclear medicine/PET, magnetic resonance (MR), computed tomography (CT) and carotid stenting. The IAC is comprised of six member divisions, each ensuring quality patient care and promoting health care within a specific medical specialty, all dedicated to one common mission.

For more information: www.icanl.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now